Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th
-
Avalyn to Participate in Multiple Upcoming Investor Conferences
-
Sunrise Realty Trust Commits $30.0 Million in a Senior Loan for Sixth & Rio Condominium Development in Fort Lauderdale
-
Enphase Energy Launches New Home Energy Systems in Romania with IQ Battery 5P and IQ8 Microinverters
-
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry
-
Alarum Achieves Significant Milestone; Fortune 200 Company Adopts its Website Unblocker Solution Following a Large-scale Evaluation
-
HWH International Inc. Launches Hapi Marketplace, a Global B2C Marketplace Platform
-
Accredited Solutions, Inc. Announces Strategic Acquisition of GlobeTopper, a $37M Revenue Platform Acquisition to Anchor Fintech Strategy
-
Tokyo Lifestyle Co., Ltd. Announces Joint Venture with Crossing Limited to Expand into Trading Card Retail Business
-
United Health Products Provides Update on FDA PMA Application
-
authID Signs $10 Million Agreement to Deliver Next Generation Authentication Security in India
-
180 Degree Capital Corp. Notes Average Discount of Net Asset Value Per Share to Stock Price for Tenth Month of Initial Measurement Period of Its Discount Management Program
-
Sunrise Realty Trust Commits $30.0 Million in a Senior Loan for Sixth & Rio Condominium Development in Fort Lauderdale
-
Southern Realty Trust Commits $60.0 Million in a Senior Loan for Sixth & Rio Condominium Development in Fort Lauderdale
-
Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings
-
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Kimco Realty® Announces Commencement of Cash Tender Offer to Purchase All of Its Outstanding Depositary Shares Representing 1/1,000 of a Share of 7.25% Class N Cumulative Convertible Perpetual Pref
-
Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies
-
FOREWARN Partners with Triad Multiple Listing Service
-
“Share Your Purple Power” This November in Honor of National Epilepsy Awareness Month
-
InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services
-
Ambassador Blackbird Wins Best in API Coding/Design Tools
-
Whitestone REIT Continues Board Refreshment with Appointment of Two Independent Trustees
-
Alignment Healthcare to Present at UBS Global Healthcare Conference and Stephens Annual Investment Conference
-
Hopebridge expands access to higher education through university partnerships
-
Janover Enters Licensing Agreement with Leading Commercial Real Estate Services Firm to Provide AI Client Engagement Tools
-
ALX Oncology Announces November Investor Conference Participation
-
MIMEDX to Participate in Upcoming Investor Conferences
-
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
-
BairesDev Named a 2024 Power Partner Award Winner by Inc.
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
4BIO Capital Strengthens Investment Team
-
Notice on Convocation of Extraordinary General Meeting of Shareholders of AB “KN Energies”
-
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
-
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
-
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval
-
Regenx Announces Facility Update
-
Bitget Wallet Lite Hits 6 Million Users in Days, Now The Largest Telegram Wallet
-
Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan
-
FTI Consulting Expands Financial Services Practice with Appointment of Two Senior Managing Directors
-
Aveanna Healthcare Holdings Announces Appointment of New Director
-
Apogee Therapeutics to Participate in Upcoming November Investor Conferences
-
Altimmune to Report Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
-
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
-
ZenaTech Announces Dual Listing of Its Shares on the Frankfurt Stock Exchange
-
Legend Biotech Appoints Alan Bash as President of CARVYKTI®
-
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement

